Fig. 4From: NR2F1 stratifies dormant disseminated tumor cells in breast cancer patientsSurvival analyses in relation to DTC dormancy profile and Ki67 status. Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 (a,c) and Ki67 profile (b,d) of DTCs (at last DIF DTC-positive bone marrow (BM) aspiration). a,b Patients being nonmetastatic at last DIF DTC-positive BMA. c,d Patients being nonmetastatic at last DIF DTC-positive BMA with no subsequent BM analysis performed. Cum cumulativeBack to article page